Sarcoidosis, Pulmonary, is a type of sarcoidosis that mainly affects the lungs. This is the most common form of the disease. It causes inflammation and the formation of granulomas (small lumps) in the lungs, which can lead to symptoms like coughing, shortness of breath, and chest pain. It can also affect other organs, but the lungs are most often involved.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Pulmonary Sarcoidosis?
Pulmonary sarcoidosis is sarcoidosis that affects the lungs and the lymph nodes in the chest. In sarcoidosis, immune cells gather into tiny inflamed clusters called granulomas. They can form almost anywhere in the body, but the lungs and chest lymph nodes are involved in about nine out of ten people with the disease. Many people have no symptoms at all, and the condition is found when a chest X-ray is done for another reason. Others develop a dry cough, shortness of breath (especially with exertion), wheezing or chest discomfort, often with tiredness, fever, night sweats or weight loss. The concern is less the granulomas themselves than what persistent inflammation can do over time: in some people it leaves permanent scarring in the lungs (pulmonary fibrosis), which makes breathing harder. One recognizable sudden form, called Lofgren syndrome, combines swollen chest lymph nodes with fever, painful, swollen joints and tender red bumps, usually on the legs, called erythema nodosum. It usually clears up completely within two years.
The cause of sarcoidosis is not known. The leading explanation is that, in people whose genes make them susceptible, the immune system overreacts to a trigger it encounters, such as an infection or something breathed in from the environment, and keeps producing granulomas instead of settling down. Several factors make it more likely. Risk rises with age, particularly after 55, and women are affected somewhat more often than men. It is more common in people of African or Scandinavian descent, and having a close relative with sarcoidosis raises risk. Black Americans are also more likely to develop more severe lung disease and involvement of other organs. Regular exposure to dusts, mold or insecticides, as can happen in farming, firefighting and some industrial jobs, has been linked to higher risk. Some medicines, including certain HIV treatments and immune-based cancer therapies, can occasionally set off a sarcoidosis-like reaction. These are associations; none of them means a particular person's sarcoidosis was caused by something they did.
No single test proves sarcoidosis. A diagnosis rests on three things: symptoms and scans that fit the condition, granulomas found in a tissue sample, and ruling out other diseases that cause similar findings, especially tuberculosis, fungal infections and lung reactions to workplace dusts such as beryllium. A chest X-ray is often the first clue, typically showing enlarged lymph nodes on both sides of the chest. Doctors describe the X-ray in stages from 0 to IV. Stage I means only the lymph nodes are enlarged; stage II adds changes in the lung tissue; in stage III the lung tissue is affected but the lymph nodes are no longer enlarged; stage IV means scarring is present. The stage gives a rough sense of outlook but does not measure how active the disease is or how someone feels. A computed tomography (CT) scan shows the lungs and lymph nodes in more detail. A tissue sample is usually needed. The most common way to get one is bronchoscopy, in which a thin flexible tube is passed through the mouth into the airways, often with an ultrasound probe (EBUS, endobronchial ultrasound) to guide a needle into the enlarged lymph nodes. If the skin or another easily reached site is involved, that may be sampled instead. A biopsy may be skipped when the picture is classic, as in Lofgren syndrome, but close follow-up then takes its place. Because sarcoidosis can affect other organs without causing symptoms, the first assessment usually also includes breathing tests (pulmonary function tests, which measure how much air the lungs hold and how well they pass oxygen into the blood), an eye exam, blood tests for calcium, kidney and liver function and blood counts, and an electrocardiogram (ECG) to check the heart's rhythm. A blood test called ACE (angiotensin-converting enzyme) is sometimes ordered, but it is not reliable enough to confirm or rule out the disease on its own.
Not everyone needs treatment. Because sarcoidosis often settles on its own, people with mild symptoms and normal or stable breathing tests are commonly monitored rather than treated. Treatment is considered when symptoms meaningfully affect daily life, when breathing tests are worsening, or when the disease threatens an important organ such as the heart, eyes or nervous system. Its aim is to calm the inflammation and protect lung function; it cannot undo scarring that has already formed. A corticosteroid pill, usually prednisone, is the standard first treatment. It works relatively quickly, but taken for months it can raise blood sugar and blood pressure, cause weight gain, mood and sleep changes, thin the bones and increase the risk of cataracts. Doctors therefore aim for the lowest dose that controls the disease and taper it over time. When steroids are needed long term, cause troublesome side effects or are not enough, a steroid-sparing medicine is added or used instead. Methotrexate, a once-weekly immune-calming medicine also used for rheumatoid arthritis, is the most common choice. One trial in people newly starting treatment found it improved lung function about as well as prednisone as a starting treatment, though it takes longer to work and requires regular blood tests to check the liver and blood counts. Azathioprine, mycophenolate and leflunomide are other immune-calming tablets used as alternatives. For disease that keeps progressing despite these, specialists may use infusions or injections that block an inflammatory signal called tumor necrosis factor (TNF), such as infliximab or adalimumab. All of these immune-lowering medicines raise the risk of infections, and some are unsafe in pregnancy, so family planning is part of choosing among them. For established lung scarring, the focus shifts to support: pulmonary rehabilitation (a supervised exercise and breathing program), oxygen if blood oxygen levels are low, and treating complications such as high pressure in the lung arteries (pulmonary hypertension). Antifibrotic medicines that slow scarring in other lung diseases are being studied in sarcoidosis, but their benefit there is not yet established. A lung transplant is an option for a small number of people with severe, advanced disease.
The course of pulmonary sarcoidosis varies widely, and the starting stage is one of the better guides. Disease limited to the chest lymph nodes clears on its own in most people, often within two years. When the lung tissue itself is inflamed, resolution is less likely, and roughly a third of people overall develop long-lasting or progressive disease. Lung scarring develops in about 10 to 20 percent of people with pulmonary sarcoidosis, and it is this group, along with those whose heart is affected, who face most of the serious long-term problems. For those who are treated, therapy often continues for a year or two before doctors try to taper it. Flares are common after stopping, affecting more than a third of people, and most happen within the first six months, which is why follow-up continues after treatment ends. Fatigue is one of the most common and frustrating parts of living with sarcoidosis and can persist even after the lungs improve. Regular physical activity and pulmonary rehabilitation can help with energy and breathlessness, and sleep problems, low mood or anxiety are worth raising, since they often add to tiredness and can be treated. Not smoking and avoiding dust, fumes and other lung irritants helps protect the lungs. Ongoing care typically includes periodic breathing tests, imaging when something changes, blood tests and an eye check, plus monitoring for side effects if you take steroids or other immune-lowering medicines. Most women with sarcoidosis have healthy pregnancies, but pregnancy carries some extra risks and some sarcoidosis medicines must be changed beforehand, so planning ahead with the care team matters.
See a clinician if you have a cough or shortness of breath that lasts for weeks without a clear cause, especially with fatigue, swollen glands or a new rash. If you already have sarcoidosis, let your care team know when breathing or exercise tolerance is gradually getting worse, since that may mean the disease is active and needs reassessment. Contact your care team promptly for eye pain or redness, blurred vision or new sensitivity to light, because sarcoidosis can inflame the eye and threaten vision. A racing, pounding or irregular heartbeat also needs prompt assessment, since sarcoidosis occasionally affects the heart's electrical system. If you take immune-lowering medicines, a fever or other sign of infection should be reported the same day. Sudden or severe shortness of breath needs emergency care. So does fainting, especially fainting without warning, during exertion, or with palpitations, chest pain or breathlessness, because in sarcoidosis it can signal a dangerous heart rhythm problem.
Last reviewed • Oct 2026
Educational content, not medical advice.
I was diagnosed with sarcoidosis early in life. It was my early 20’s when I ended up in the hospital and left 3.5 weeks later with a prednisone prescription and a diagnosis. How old were you when you were diagnosed?